Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color. Part II: differences in clinical presentation and disparities in cutaneous disorders …
S McKenzie, JB Brown-Korsah, NC Syder… - Journal of the American …, 2022 - Elsevier
Skin of color (SOC) patients are projected to comprise the majority of the population by
2044, yet knowledge gaps in the clinical presentation and treatment of both common and …
2044, yet knowledge gaps in the clinical presentation and treatment of both common and …
Racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis, and psoriasis: a comprehensive review
A Sevagamoorthy, P Sockler, C Akoh… - Journal of …, 2022 - Taylor & Francis
An increasing body of literature describes underreporting of race and ethnicity, and
overrepresentation of White individuals in clinical trials. We aimed to evaluate the racial and …
overrepresentation of White individuals in clinical trials. We aimed to evaluate the racial and …
Unmet need in people with psoriasis and skin of color in Canada and the United States
G Yadav, J Yeung, Y Miller-Monthrope… - Dermatology and …, 2022 - Springer
The experience of dermatological conditions such as psoriasis is different for people with
skin of color (SoC) than for white individuals. The objective of this literature review was to …
skin of color (SoC) than for white individuals. The objective of this literature review was to …
Racial/ethnic differences in treatment efficacy and safety for moderate-to-severe plaque psoriasis: a systematic review
JE Ferguson, EW Seger, J White… - Archives of Dermatological …, 2023 - Springer
Biologic medications have revolutionized treatment of psoriasis; however, there remains
uncertainty in which medications should be used to maximize efficacy based on …
uncertainty in which medications should be used to maximize efficacy based on …
A pilot study to assess the reliability of digital image-based PASI scores across patient skin tones and provider training levels
D Wu, X Lu, M Nakamura, S Sekhon, C Jeon… - Dermatology and …, 2022 - Springer
Introduction The ability to perform psoriasis skin assessments remotely through digital image-
based psoriasis area and severity index (DIB-PASI) would be a valuable tool for psoriasis …
based psoriasis area and severity index (DIB-PASI) would be a valuable tool for psoriasis …
Transforming the treatment of psoriasis to the 21st century: Detecting subclinical therapeutic response to secukinumab using optical coherence tomography as a …
S Felice, MY Bressler, R Karim… - Lasers in Surgery and …, 2022 - Wiley Online Library
Background Optical coherence tomography (OCT) is a noninvasive imaging device that
scans the skin up to 2 mm in depth. OCT can capture real‐time epidermal thickness (ET) …
scans the skin up to 2 mm in depth. OCT can capture real‐time epidermal thickness (ET) …
Racial disparities in clinical trials of biologic treatments for psoriatic arthritis
S Shwe, C Nguyen, T Bhutani - Journal of the American Academy of …, 2022 - jaad.org
REFERENCES 1. Jiang Y, Redmond D, Nie K, et al. Deep sequencing reveals clonal
evolution patterns and mutation events associated with relapse in B-cell lymphomas …
evolution patterns and mutation events associated with relapse in B-cell lymphomas …
Efficacy and Safety of Risankizumab in Patients with Psoriasis Showing Suboptimal Response to Secukinumab or Ixekizumab: Results from a Phase 3b, Open-Label …
RB Warren, L Pavlovsky, A Costanzo, M Bukhalo… - Dermatology and …, 2024 - Springer
Methods This 52-week, phase 3b study enrolled patients (≥ 18 years) with moderate-to-
severe plaque psoriasis who had previously been treated with the recommended dose of …
severe plaque psoriasis who had previously been treated with the recommended dose of …
Disparities in psoriasis clinical trials: A cross-sectional analysis
J Ding, M Joseph, S Chawla, N Yau, Z Khosa… - Journal of the American …, 2022 - jaad.org
To the Editor: With the advent of biologic treatments for psoriasis, well-designed clinical trials
are critical to provide safety and efficacy data. Differences in psoriasis susceptibility due to …
are critical to provide safety and efficacy data. Differences in psoriasis susceptibility due to …
Ethnoracial representation in hidradenitis suppurativa clinical trials
Background Hidradenitis suppurativa (HS) is an inflammatory skin disorder characterized by
recurring painful and suppurating lesions, with the disease disproportionately affecting black …
recurring painful and suppurating lesions, with the disease disproportionately affecting black …